An error occurred retrieving publication content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
Study found that, in the short term, there is little clinical difference between deferasirox, deferoxamine and deferiprone in terms of removing iron from the blood and liver, and that deferasirox may be cost-effective compared with deferoxamine in patients with beta-thalassaemia and sickle cell disease but is unlikely to be cost-effective compared with deferiprone
1 Liverpool Reviews and Implementation Group, University of Liverpool, , UK
2 Centre for Medical Statistics and Health Evaluation, University of Liverpool, , UK
3 University of Liverpool Management School, Liverpool, UK
4 Royal Liverpool University Hospital, Liverpool, UK
5 University College London, , UK
6 University Hospital Aintree, Liverpool, UK
7 Queen Mary, University of London, , UK
* Corresponding author Email: r.dickson@liv.ac.uk
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.
An error has occurred in processing the XML document